Court gives final approval to Bayer's $7.25 billion Roundup settlement

A Missouri court on November 20 gave final approval to Bayer's $7.25 billion settlement resolving tens of thousands of claims that the weedkiller Roundup caused non-Hodgkin lymphoma. Bayer will pay over up to 21 years, with individual awards of about $10,000 to $165,000; the deal admits no liability, and Bayer still says Roundup is safe.
A St. Louis circuit court judge, Timothy Boyer, granted final approval on November 20 to Bayer's settlement of up to $7.25 billion, resolving tens of thousands of current and future claims in the United States alleging that the weedkiller Roundup caused non-Hodgkin lymphoma. The judge described the total as among the largest in the history of US mass-tort personal-injury class actions.
Paid over 21 years, with awards up to $165,000
Under the deal, Bayer will pay the $7.25 billion in instalments over up to 21 years. Individual awards will range from about $10,000 to $165,000, depending on the extent of exposure to Roundup, the age at diagnosis and the severity of the illness. The settlement includes $600 million in attorneys' fees. Bayer admits no liability or fault, and the approval order can be appealed.
Deal reached in February after a Supreme Court ruling weakened plaintiffs
The settlement was reached in February. It followed a US Supreme Court ruling in June in the Durnell case, in which the court voted 7–2 to overturn a $1.25 million jury award, weakening the plaintiffs' failure-to-warn claims and clouding the outlook for large-scale litigation.
Bayer still insists the product is safe
Bayer continues to insist that Roundup is safe and denies that glyphosate causes cancer. Even so, Roundup litigation has already cost the company heavily in settlements and verdicts over the years; if this $7.25 billion class settlement survives appeal, it would close a legal battle that has dragged on for years.
N環球 
💬 Comments
No comments yet. Be the first!